Biotech 2050 Podcast
Conquering new frontiers in cell therapy, Paul Lammers, CEO, Triumvira Immunologics
about a year ago
Next-gen immunotherapies for cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma
about a year ago
Transforming medicine through non-viral gene therapy, Theresa Heah, CEO, Intergalactic Tx
about a year ago
Transforming diseased cells into coordinators of cure, Volker Herrmann, President & CEO, Sonata Tx
about a year ago
Breaking barriers in rare genetic mitochondrial diseases, Greg Flesher, Pres. & CEO, Reneo
about a year ago
Correcting abnormal gene expression in oncology, Adrian Gottschalk, Pres. & CEO, Foghorn Tx
about a year ago
Epigenetic therapies for organ injury & chronic liver diseases, Jim Brown, Pres. & CEO, DURECT
about a year ago